Ivoclar Vivadent AG
Schaan, 9494, Liechtenstein
NCT Number: NCT06898411
This retrospective study investigates the longevity of lithium disilicate based glass-ceramic single tooth restorations placed with IPS e.max CAD and IPS e.max Press after a wearing period of more than 15 years. The primary objective is to assess the survival rate of single tooth restorations with IPS e.max CAD and IPS e.max Press after a wearing period of at least 15 years. The secondary objectives are to assess the quality of the single tooth restorations in regard of aesthetic, functional and biological properties.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Schaan, 9494, Liechtenstein
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Examination of single tooth restorations with IPS e.max after a wearing time of more than 15 years. Intraoral situation will be examined similar to a standard dental examination while single tooth restorations will be documneted by photos.
Time frame: 15 years
Study population recieved single tooth restorations with IPS e.max between 2006-2010. After a wearing time of more than 15 years IPS e.max single tooth restorations were examined by a dentist resulting in survival rates of IPS e.max single tooth restorations after 15 years.
Ivoclar Vivadent AG
Industry
Retrospective Clinical Study to Investigate the Longevity of Long-term Single Tooth Restorations From IPS e.Max CAD and Press
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07322224
Biological Aging, Healthy Aging
London, United Kingdom
View Trial DetailsNCT06613542
Aging, Biological, Anti-Aging
Munich, Germany
View Trial DetailsNCT07727915
Autoimmune, Fragility
Medellín, Antioquia, Colombia
View Trial DetailsNCT07719088
Aging, Biomarkers of Aging
Edwards, Colorado, United States
View Trial Details